Author
University of North Carolina at Chapel HillORCID 0009-0008-9180-195XUnclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Matthew P. Zimmerman, Vasyl Zhabotynsky, Haiyang Wang…·Brian C. Miller
This study identifies folate receptor beta (FRβ) as a metabolic checkpoint on tumor-associated macrophages (TAMs) that promotes immunosuppression and tumor growth.
Alexander Gevelinger Bastian, Eric W. Livingston, Matthew P. Zimmerman…·Brian C. Miller
This study compares immune phenotypes and activation states in bone marrow chimeras after irradiation with cesium-137 or X-ray sources, finding no significant differences.
Matthew P. Zimmerman, Amy Y. Huang, Emily K. Cox…·Brian C. Miller
This study shows CD40 agonist therapy reduces tumor growth in antigen presentation-deficient tumors by reprogramming monocytes and requiring IFN-gamma and CD8+ T cells for efficacy.